Penserra Capital Management LLC Ngm Biopharmaceuticals Inc Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$17.26 - $22.02 $30,463 - $38,865	-1,765 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$20.15 - $26.19 $201 - $261	10 Added 0.57%	1,765 $37,000
Q2 2021 Aug 12, 2021	BUY	$15.06 - $30.03 $1,355 - $2,702	90 Added 5.41%	1,755 $34,000
Q1 2021 May 13, 2021	BUY	$24.99 - $31.93 $1,999 - $2,554	80 Added 5.05%	1,665 $48,000
Q4 2020 Feb 12, 2021	BUY	$16.21 - $31.44 $16,161 - $31,345	997 Added 169.56%	1,585 $48,000
Q3 2020 Nov 13, 2020	BUY	$15.59 - $19.97 $9,166 - $11,742	588 New	588 $9,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.